SCHEMBL4899227

SCHEMBL4899227

Cc1ccc(S(=O)(=O)NCCSc2n[nH]c(-c3ccccc3)n2)cc1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.53
GRK6 P43250 4/20 0.50
ALPL P05186 2/20 0.47
KDM4E B2RXH2 1/20 0.46
POLB P06746 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
HTR7 P34969 1/20 0.45
HPGD P15428 2/20 0.45
KMT2A Q03164 2/20 0.45
ALDH1A1 P00352 4/20 0.44
MEN1 O00255 1/20 0.44
TSHR P16473 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TP53 P04637 1/20 0.44
MAPT P10636 1/20 0.44
ALOX15 P16050 1/20 0.43
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906148 0.93 GRK6 (0.48) LMNAGRK6ALPLHTR7HPGD
SCHEMBL4906791 0.77 LMNA (0.53) LMNAKDM4EPOLBL3MBTL1HTR7
SCHEMBL4894575 0.77 LMNA (0.54) LMNAKDM4EPOLBL3MBTL1HPGD
SCHEMBL4899232 0.76 GRK6 (0.42) LMNAGRK6ALPLHTR7HPGD
SCHEMBL4906166 0.74 MAPT (0.55) LMNAPOLBL3MBTL1HPGDKMT2A
SCHEMBL4903885 0.73 LMNA (0.57) LMNAKDM4EPOLBL3MBTL1ALDH1A1
SCHEMBL4902479 0.72 LMNA (0.55) LMNAKDM4EPOLBL3MBTL1KMT2A
SCHEMBL4906163 0.72 KMT2A (0.44) LMNAGRK6KDM4EHPGDKMT2A
SCHEMBL4908216 0.71 LMNA (0.54) LMNAKDM4EPOLBL3MBTL1KMT2A
SCHEMBL4899383 0.71 LMNA (0.59) LMNAKDM4EPOLBL3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885GRK6 1667/4885ALPL 1968/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885GRK6 1667/4885ALPL 1968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.